Background: Tramadol is routinely used analgesic postoperatively in ICU patients, it is known to cause nausea and vomiting. Pharmacologically it has analgesic action, centrally as it blocks the reuptake of serotonin at spinal pathway. Ondansetron is a serotonin receptor antagonist used in postoperative time, cancer chemotherapy, radiation therapy, as an anti-emetic. In-spite of known pharmacological antagonism centrally, these two drugs are routinely used together postoperatively. The purpose of this study was to assess tramadol's analgesic efficacy when given alone versus when given along with ondansetron. Requirement of rescue analgesic and side effects like sedation, nausea and vomiting amongst two groups were also evaluated. Methods: This prospective randomized study was conducted at surgical ICU enrolling 60 patients. We have separated patients into two groups of 30 each. Group A was given 100milligram of injection tramadol intravenously slowly over ten minutes and after 12mg/hour tramadol plus ondansetron in the dose of 0.8mg/hour. Group B was given 100milligram of injection tramadol slowly over ten minutes followed by infusion of tramadol 12mg/hour. In both A and B groups, hemodynamic parameters were evaluated at 0, 3, 6, 12, and 24 hours along with pain assessment using the Visual Analog Scale (VAS) in the range of 0 to 10. Rescue analgesia was administered in the form of paracetamol 1 gram IV at any time if VAS > 4. A four point ordinal scale was used to measure side effects such as nausea, vomiting, and the degree of sedation. Results: In group A, postoperative VAS scores were higher up to 24 hours compared to group B, suggesting greater analgesia in the tramadol infusion group only. There was a significant difference when both the groups were compared with respect to requirement of rescue analgesia with 4 patients in group A and no patient in group B requiring rescue analgesia. No significant difference was found with respect to nausea and vomiting and the degree of sedation in both classes. Conclusion: In ICU patients administration of tramadol along with ondansetron should not be practiced as ondansetron decreases the analgesic efficacy of tramadol.
Cite this article:
Nikhil Bhalerao, Amol Singam. Co-administration of Ondansetron with Tramadol Decreases efficacy of Tramadol in Intensive Care unit patients. Research Journal of Pharmacy and Technology. 2021; 14(6):3157-0. doi: 10.52711/0974-360X.2021.00550
Nikhil Bhalerao, Amol Singam. Co-administration of Ondansetron with Tramadol Decreases efficacy of Tramadol in Intensive Care unit patients. Research Journal of Pharmacy and Technology. 2021; 14(6):3157-0. doi: 10.52711/0974-360X.2021.00550 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-6-40
1. Milne RJ, Heel RC. Ondansetron. Therapeutic use as an antiemetic. Drugs 1991; 41: 574 95.
2. Lee CR, McTavish D, Sorkin EM. Tramadol: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993; 46: 313 40.
3. Millan MJ. The role of descending noradrenergic and serotoninergic pathways in the modulation of nociception: Focus on receptor multiplicity. In: Dickenson AH, Melmon KL, Besson JM, editors. Handbook of Experimental Pharmacology. Vol. 130. The pharmacology of pain, 6th ed. Heidelberg Springer Verlag; 1997. 385 446.
4. Vickers MD. The efficacy of tramadol hydrochloride in the treatment of postoperative pain. Rev Contemp Pharmacother 1995;6: 499 506.
5. Peroutka SJ, Snyder SH. Antiemetics: Neurotransmitter receptor binding predicts therapeutic actions. Lancet 1982;1: 658 9.
6. Tramèr MR, Reynolds DJ, Stoner NS, Moore RA, McQuay HJ. Efficacy of 5 HT3 receptor antagonists in radiotherapy induced nausea and vomiting: A quantitative systematic review. Eur J Cancer 1998; 34: 1836 44.
7. Robert K. Stoelting and Simon C. Hillier; Pharmacology and Physiology in Anesthetic Practice, 4th Edition, Chapter 3, Opioid Agonists and Antagonists; Pages 87-126.65. Wilde MI, Markan A. Ondansetron – a review of its pharmacology and preliminary clinical findings in novel application. Drugs 1996; 52(5).
8. Smith RN. Safety of ondansetron. Eur J Cancer Clin Oncol 1989; 25(1): S47-50.
9. Thomas A. Torda Postoperative analgesia Aust Prescr 1995; 18: 88-91 (Published on 1st October 1995)
10. Dayer P, Desmeules J, Collart L. Pharmacology of tramadol. Drugs 1997; 53Suppl 2: 18 24.
11. Cui M, Feng Y, McAdoo DJ, Willis WD. Periaqueductal gray stimulation induced inhibition of nociceptive dorsal horn neurons in rats is associated with the release of norepinephrine, serotonin, and amino acids. J Pharmacol Exp Ther 1999; 289: 868 76.
12. Rao SM, Netke B, Ponavala T, Kumar S, Dharmarakshak A. Post operative pain relief by PCA v/s oral tramadol in cardiac surgery. Ann Card Anaesth 2001; 4: 13 6.
13. Arcioni R1, della Rocca M, Romanò S, Romano R, Pietropaoli P, Gasparetto A Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans Anesthesia and analgesia. 94(6): 1553-7
14. Rauers NI, Stüber F, Lee E, et al. Antagonistic effects of ondansetron and tramadol? A randomized placebo and active drug controlled study. J Pain. 2010; 11(12): 1274–81.10.1016/j.jpain.2010.03.003
15. Vale C, Oliveira F, Assunção J, Fontes Ribeiro C, Pereira F. Co administration of ondansetron decreases the analgesic efficacy of tramadol in humans. Pharmacology 2011; 88: 182 7.